Summary of Events
Sunflower Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") held its 2026 Annual General Meeting on April 24, 2026, where it approved the deregistration of its wholly-owned subsidiary, Hainan Sunflower Pharmaceutical Co., Ltd. (hereinafter referred to as "Hainan Sunflower"). The deregistration will take effect on April 27, 2026.
Progress of Deregistration of Subsidiary
The Company has recently completed the necessary procedures for the deregistration of Hainan Sunflower and has obtained the new registration notice from the local regulatory authority. This announcement will not affect the overall financial status of the Company, particularly its small and medium-sized shareholders.
Supporting Documents
- Deregistration Notice
[blank]
This announcement is issued by Sunflower Pharmaceutical Group Co., Ltd.
Board of Directors
May 19, 2026